Summary of HRES 394: Glioblastoma Awareness Day Resolution

Bill Overview

• Bill Number: HRES 394
• Title: Expressing support for the designation of July 16, 2025, as "Glioblastoma Awareness Day"
• Status: Submitted in House
• Introduced: May 06, 2025
• Classification: Resolution

Purpose and Intent

HRES 394 aims to raise awareness about glioblastoma, a highly aggressive form of brain cancer, by designating July 16, 2025, as "Glioblastoma Awareness Day." The resolution seeks to honor those affected by the disease and promote efforts for better treatment options and research.

Key Provisions

The resolution includes several important provisions:

1. Support for Awareness: Expresses support for the establishment of Glioblastoma Awareness Day.
2. Public Awareness: Encourages increased public understanding of glioblastoma and its impacts.
3. Honoring Affected Individuals: Pays tribute to individuals who have lost their lives to glioblastoma and those currently living with the disease.
4. Treatment Development: Supports initiatives aimed at improving treatments and long-term prognoses for glioblastoma patients.
5. Molecular Biomarker Testing: Recognizes the significance of molecular biomarker testing in diagnosing and treating glioblastoma.
6. Support for Patients and Caregivers: Expresses solidarity with patients battling brain tumors, as well as their families and caregivers.
7. Collaborative Research: Urges a cooperative approach to brain tumor research involving government, private, and nonprofit sectors to enhance understanding and treatment options.
8. Investment in Research: Encourages ongoing investments in glioblastoma research and treatment initiatives, including support for the Glioblastoma Therapeutics Network.

Affected Parties

The resolution primarily impacts:
- Individuals diagnosed with glioblastoma
- Families and caregivers of glioblastoma patients
- Researchers and healthcare providers involved in brain tumor treatment and research
- Advocacy groups focused on cancer awareness and research funding

Legislative Actions

• 2025-05-06: The resolution was referred to the House Committee on Energy and Commerce.
• 2025-05-06: The resolution was submitted in the House.

Sponsors

The resolution has a broad range of support from various sponsors, including:
- Primary Sponsor: Roger Williams
- Cosponsors: Chrissy Houlahan, Jamie Raskin, Donald G. Davis, Eric Sorensen, Daniel S. Goldman, Doris O. Matsui, Haley M. Stevens, Eleanor Holmes Norton, Suzan K. DelBene, Julia Brownley, Suzanne Bonamici, Salud O. Carbajal, Jake Auchincloss, Debbie Dingell, Janice D. Schakowsky, Jerrold Nadler, Brian J. Mast, Deborah K. Ross, Nikki Budzinski.

Related Legislation

• SRES 285: A companion resolution in the Senate that aligns with the goals of HRES 394.

This resolution serves as a significant step towards increasing awareness and support for glioblastoma, fostering a collaborative environment for research and treatment advancements.